Investors have been left with mixed emotions regarding the stock price performance over the year, as it’s been a mixed bag. Year to date metric has recorded a loss of -43.55%.However, over the last six months, we can see a stronger performance of -4.97%. Over the last 30 days, the price of EVH has fallen by 35.53%. And in the last five days, it has fallen by -2.92%.
Evolent Health Inc’s stock has seen a smooth market performance. The company’s stock achieved a 1-year high of $33.63 on 08/26/24, and the lowest price during that time was $7.06, recorded on 05/23/25.
52-week price history of EVH Stock
The history of a stock’s 52-week high and low prices can provide important information about its current state and future potential. Evolent Health Inc’s current trading price is -66.43% away from its 52-week high, while its distance from the 52-week low is 59.92%. The stock’s price range for this period has been between $7.06 and $33.63. The Healthcare sector company’s shares saw a trading volume of about 2.66 million for the day, which was higher than the average daily volume of 2.61 million over the last three months.
The Connection Between Financial Performance and Market Capitalization
Evolent Health Inc (EVH) has experienced a quarterly rise of 20.11% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 1.33B and boasts a workforce of 4500 employees.
How Moving Averages and Trading Volume Data Work Together
EVH’s Debt-to-Equity Ratio: A Comprehensive Review
A key metric for assessing a company’s financial well-being and market status is the debt-to-equity (D/E) ratio. This ratio is derived by dividing a company’s total liabilities by its shareholders’ equity, and it demonstrates the level of debt a company uses to support its assets relative to shareholder equity. At the time of writing, the total D/E ratio for EVH stands at 1.14. Similarly, the long-term debt-to-equity ratio is also 0.92.
